{"concreteType":"org.sagebionetworks.repo.model.table.QueryResultBundle","queryResult":{"concreteType":"org.sagebionetworks.repo.model.table.QueryResult","queryResults":{"concreteType":"org.sagebionetworks.repo.model.table.RowSet","tableId":"syn16859580","etag":"65210784-44a2-46e6-bfe9-d190ca2a9835","headers":[{"name":"id","columnType":"ENTITYID","id":"2510"},{"name":"datasetName","columnType":"LARGETEXT","id":"70044"},{"name":"diseaseFocus","columnType":"STRING","id":"56918"},{"name":"tumorType","columnType":"STRING","id":"39539"},{"name":"summary","columnType":"LARGETEXT","id":"69194"},{"name":"fundingAgency","columnType":"STRING","id":"38862"},{"name":"fileCount","columnType":"INTEGER","id":"70045"},{"name":"fileSize","columnType":"INTEGER","id":"31167"},{"name":"featured","columnType":"STRING","id":"71578"}],"rows":[{"rowId":0,"versionNumber":20,"values":["syn16812247","Synodos NF2 RNASeq (Processed)","Neurofibromatosis 2","Schwannoma | Meningioma","This set contains counts-level and differential expression data files for NF2 schwannoma and meningioma models that were treated with vehicle control or HDAC, PI3K, and mTOR inhibitors. ","CTF","13","45893643","yes"]},{"rowId":1,"versionNumber":11,"values":["syn16815129","Synodos NF2 Drug Screening (Raw and Processed)","Neurofibromatosis 2","Schwannoma | Meningioma","This set contains raw and processed drug screening data for NF2 schwannoma and meningioma models generated that were tested with a panel of 19 experimental therapeutics and drugs.","CTF","3","351612",null]},{"rowId":8,"versionNumber":19,"values":["syn17023505","Drug Target Explorer v2","Multiple","Multiple","The Drug Target Explorer v2 dataset contains structural, molecular fingerprint, and target information for approximately 300k small molecules and500k molecule-target associations. ","CTF","12","139674049",null]}]}},"selectColumns":[{"name":"id","columnType":"ENTITYID","id":"2510"},{"name":"datasetName","columnType":"LARGETEXT","id":"70044"},{"name":"diseaseFocus","columnType":"STRING","id":"56918"},{"name":"tumorType","columnType":"STRING","id":"39539"},{"name":"summary","columnType":"LARGETEXT","id":"69194"},{"name":"fundingAgency","columnType":"STRING","id":"38862"},{"name":"fileCount","columnType":"INTEGER","id":"70045"},{"name":"fileSize","columnType":"INTEGER","id":"31167"},{"name":"featured","columnType":"STRING","id":"71578"}],"columnModels":[{"id":"2510","name":"id","columnType":"ENTITYID"},{"id":"70044","name":"datasetName","columnType":"LARGETEXT"},{"id":"56918","name":"diseaseFocus","columnType":"STRING","maximumSize":50,"facetType":"enumeration"},{"id":"39539","name":"tumorType","columnType":"STRING","maximumSize":50,"facetType":"enumeration"},{"id":"69194","name":"summary","columnType":"LARGETEXT"},{"id":"38862","name":"fundingAgency","columnType":"STRING","maximumSize":50,"facetType":"enumeration"},{"id":"70045","name":"fileCount","columnType":"INTEGER"},{"id":"31167","name":"fileSize","columnType":"INTEGER"},{"id":"71578","name":"featured","columnType":"STRING","maximumSize":3,"enumValues":["yes"]}],"facets":[{"concreteType":"org.sagebionetworks.repo.model.table.FacetColumnResultValues","columnName":"diseaseFocus","facetType":"enumeration","facetValues":[{"value":"Multiple","count":1,"isSelected":false},{"value":"Neurofibromatosis 2","count":2,"isSelected":false}]},{"concreteType":"org.sagebionetworks.repo.model.table.FacetColumnResultValues","columnName":"tumorType","facetType":"enumeration","facetValues":[{"value":"Multiple","count":1,"isSelected":false},{"value":"Schwannoma | Meningioma","count":2,"isSelected":false}]},{"concreteType":"org.sagebionetworks.repo.model.table.FacetColumnResultValues","columnName":"fundingAgency","facetType":"enumeration","facetValues":[{"value":"CTF","count":3,"isSelected":false}]}]}